Emerging studies show that dysregulated RACK1 is supposed to be a biomarker or regulator in a wide spectrum of human cancers [15,16,17,18,19,20,21], which implies that RACK1 could play an important role in genesis and progression [18,22] as well as resistance to chemotherapy in tumors [23]. Here, RACK1 is linked to cancer.